COMBAT: Computer Based Assessment and Treatment

Sponsor
Norwegian University of Science and Technology (Other)
Overall Status
Completed
CT.gov ID
NCT01795157
Collaborator
St. Olavs Hospital (Other)
255
1
2
41
6.2

Study Details

Study Description

Brief Summary

This study aims to investigate computer based symptom assessment in an outpatient cancer population, and the use of a computer based decision support system to facilitate the diagnosis and treatment of cancer related pain.

Primary hypothesis is, that this approach improves pain control and pain management in an unselected group of cancer patients in an outpatient setting.

  • Improvement of average pain last 24 hours by at least 1.5 points on a 0-11 scale

  • Improvement of worst pain last 24 hours by at least 1.5 points on a 0-11 scale

  • An alteration in the prescribing dose of opioids in equipotent opioid dosage

Secondary hypothesis is, that this system improves overall symptom control and symptom management in an unselected group of cancer patients in an outpatient setting.

Condition or Disease Intervention/Treatment Phase
  • Device: CCADSS
  • Device: pen-paper
N/A

Detailed Description

The traditional way of symptom assessment is by the paper-and-pen method, which suffers from several limitations. The assessment items are not individually adjusted to each patient and his/her subjective symptoms, the collected data is rarely used in clinical practice, and decision-support for the physician is not possible.

Although the body of evidence is accumulating regarding the benefits of computerised symptom assessment in cancer patients, there is still insufficient knowledge of the impact of computerised assessment tools on the management of cancer pain and other cancer related symptoms.

The COMBAT study aims to investigate if a computer based assessment of cancer related symptoms, and a computerized decision support can improve treatment of pain and other symptoms in cancer patients.

This is an open, comparative study with a sequential design with two consecutive study periods, the non-intervention period and the intervention period.

The computer-based clinical decision support system will utilize the following data to generate one or several treatment options:

  1. Data from self assessment of cancer related symptoms

  2. Data from relevant variables reported by the physician

  3. Revisited guidelines on treatment of cancer pain

Study Design

Study Type:
Interventional
Actual Enrollment :
255 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Computer Based Assessment and Treatment
Actual Study Start Date :
Sep 1, 2009
Actual Primary Completion Date :
Feb 1, 2013
Actual Study Completion Date :
Feb 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: CCADSS

questionnaire completed using i-Pad

Device: CCADSS
Questionnaire is transferred wireless to the physician's PC

Active Comparator: pen-paper

Questionnaire completed using pen and paper

Device: pen-paper
Questionnaire completed and transferred to the physician using standard methods

Outcome Measures

Primary Outcome Measures

  1. average and worst pain during the last 24 hours [1 week]

    - The Brief Pain Inventory (BPI, a self-reported pain assessment tool aiming to quantify two aspects of cancer pain: Pain intensity and the functional disability as a result of cancer pain.

  2. average and worst pain during the last 24 hours [3 weeks]

    - The Brief Pain Inventory (BPI, a self-reported pain assessment tool aiming to quantify two aspects of cancer pain: Pain intensity and the functional disability as a result of cancer pain.

  3. average and worst pain during the last 24 hours [1 week]

    - The Alberta Breakthrough Pain Assessment Tool for cancer patients (ABPAT), a questionnaire developed in order to measure several dimensions of cancer-related breakthrough pain. It contains 15 questions, and was translated into Norwegian by our research group according to EORTC's rules for translation.

  4. average and worst pain during the last 24 hours [3 weeks]

    - The Alberta Breakthrough Pain Assessment Tool for cancer patients (ABPAT), a questionnaire developed in order to measure several dimensions of cancer-related breakthrough pain. It contains 15 questions, and was translated into Norwegian by our research group according to EORTC's rules for translation.

Secondary Outcome Measures

  1. symptoms [1 week]

    - The Edmonton Symptom Assessment System (ESAS), a validated standardized questionnaire consisting of 10 items, which evaluate physical and psychological symptoms as well as general wellbeing.

  2. symptoms [3 weeks]

    - The Edmonton Symptom Assessment System (ESAS), a validated standardized questionnaire consisting of 10 items, which evaluate physical and psychological symptoms as well as general wellbeing.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • attending the outpatient clinic at the Cancer Clinic, St. Olavs Hospital Trondheim

  • histologically verified malignancy

  • able to follow study instructions

  • able to read the information on the computer screen in the intervention period of the study

  • able to use a touch screen in the intervention period of the study

  • cancer related pain measured as average pain in last 24 hours of 4 or above on a numeric rating scale

  • elective or emergency consultation with a physician

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Oncology outpatient clinic, St Olavs Hospital Trondheim Norway

Sponsors and Collaborators

  • Norwegian University of Science and Technology
  • St. Olavs Hospital

Investigators

  • Study Director: Stein Kaasa, MD prof, Norwegian University of Science and Technology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT01795157
Other Study ID Numbers:
  • 2009/859
First Posted:
Feb 20, 2013
Last Update Posted:
Sep 25, 2017
Last Verified:
Sep 1, 2017
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Norwegian University of Science and Technology

Study Results

No Results Posted as of Sep 25, 2017